1.Pingyangmycin injection under suspension laryngoscopy for giant hemangioma at hypopharynx and laryngeal in 12 cases hemangioma at hypopharynx and laryngeal in 12 cases.
Lang GUO ; Shusen LIU ; Ping JIANG ; Weiwei HENG ; Weidong SHOU
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2014;28(9):647-649
OBJECTIVE:
To explore the therapeutic methods and effect of pingyangmycin injection in huge hemangioma at Hypopharynx and laryngeal under suspension laryngoscopy.
METHOD:
To ananysize the medical records of 12 Patients with giant hemangioma at hypopharynx and laryngeal. Patients were underwent polysomnography before operation. Inseted the suspension laryngoscopy to pars laryngea by mouth to exposing the hemangioma under general anaesthesia, then injected Pingyangmycin by a long-tube needling (one time per three weeks, accumulated dose less than 50 mg).
RESULT:
Among all patients, ten were cured and two showed obvious improvement. The data of PSG after operation indicates that the symptom of anoxia of post-operation were significantly ameliorated than that of pre-operation, no recurrence occurred during one year follow-up of the hemangioma.
CONCLUSION
The methods of pingyangmycin injection under suspension laryngoscopic surgery is significantly enhanced clinical effect and improved the life quality of patients with huge hemangioma, which with low risk, high security, can ameliorating anoxia, complete cure, and is a ideal therapeutic measure.
Adult
;
Bleomycin
;
administration & dosage
;
analogs & derivatives
;
Female
;
Hemangioma
;
therapy
;
Humans
;
Hypopharynx
;
pathology
;
Laryngoscopy
;
Larynx
;
pathology
;
Male
;
Middle Aged
;
Treatment Outcome
;
Young Adult
2.Analysis on the epidemiologic characteristics of human rabies in all the 31 provinces in China, from 1991 to 2005.
Shou-heng GUO ; Qing TANG ; Hao LI ; Fu-qiang LIU
Chinese Journal of Epidemiology 2007;28(4):374-376
OBJECTIVETo study the epidemic intensity and trend of human rabies from 1991 to 2005 among 31 provinces, metropoli and municipalities in China so as to increase the awareness of the disease.
METHODSContrastive analyses were performed and the annual publishing data by the Chinese Center for Disease Control and Prevention were used.
RESULTSThe total number of reported cases was 14 942 from 1991 to 2005 with an annual average mortality rate as 0.080/100000. The increase of five-years mortality ratio on relative ratio with circular base of mortality rate were--66.24% (1996-2000 to 1991-1995) and 506.13% (2001-2005 to 1996-2000). When comparing incidence rates between 2000-2005 and 1991-1995, the relative ratio with fixed base increase became 104.62%.
CONCLUSIONAmong the 31 provinces, metropolis and municipalities, 27 had reported human rabies cases. The enzootic areas mainly distributed in the drainage area along the Yangtze River. The incidence rates of Guangxi, Hunan, Guizhou, Jiangxi and Guangdong were the highest.
China ; epidemiology ; Disease Outbreaks ; Humans ; Incidence ; Rabies ; epidemiology
3.Analysis on the epidemiology of rabies in Hunan province in the past 10 years.
Qi-you XIAO ; Xiang-di WANG ; Su-bang KANG ; Shou-heng GUO ; Shen-gen WEN
Chinese Journal of Epidemiology 2005;26(6):428-430
OBJECTIVETo explore the possible factors causing the increase of rabies cases and to provide references for the development of related prevention and control strategy in Hunan.
METHODSData was collected and analyzed on epidemic situation of rabies in the past ten years, and studies were carried in some counties.
RESULTSFrom 1994 to 1999, the annual cases sustained between 17 and 78. However, the number of cases has continued to increase since 2000. The annual reported cases in 2001 and 2002 were 311 and 313, and accounted for 34.8% and 30.0% of the total cases in the whole country respectively. The epidemic areas were mainly located in the south and middle parts of Hunan. Furthermore, the epidemic areas had been expanding. In 1997, human rabies cases were only reported in 7 cities but increased to 12 cities in 2004.
CONCLUSIONFactors as increasing number but low inoculating rate to dogs, and incorrect treatment on the wounds etc. might have served important roles for the recurrence of rabies. Hence, it is necessary to take comprehensive preventive measures to control and prevent the epidemics of rabies in Hunan.
Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; China ; epidemiology ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Rabies ; epidemiology
4.Comparative study on three types of digestive reconstruction after total gastrectomy.
Hong-bo WEI ; Bo WEI ; Zong-heng ZHENG ; Feng ZHENG ; Wan-shou QIU ; Wei-ping GUO ; Tu-feng CHEN ; Tian-bao WANG
Chinese Journal of Gastrointestinal Surgery 2006;9(4):301-304
OBJECTIVETo investigate the rational digestive reconstruction after total gastrectomy for gastric malignancy.
METHODSThree types of digestive reconstruction were performed after total gastrectomy in 189 cases with gastric carcinoma. The operating time, morbidity and mortality, food intake, digestive tract symptoms, nutritional status at 1 and 3 years after surgery and 1-, 3-, 5-year cumulative survival were compared.
RESULTSThere were no significant differences among the three procedures in operative morbidity and mortality, postoperative food intake, nutritional status (Hemoglobin, total protein and labium), and incidences of diarrhea and dumping syndrome (P > 0.05). The overall 1-, 3-, 5-year survival rates were 75.3%, 38.2% and 20.5% respectively, and there were no significant differences among the three groups (P > 0.05). Orr-type and P-type esophagojejunostomy had an advantage of anti-esophageal reflux, and were obviously superior to Moynihan-type anastomosis (P< 0.01). Compared with P-type reconstruction, Orr-type reconstruction was simpler with shorter operating time, and less complications.
CONCLUSIONSOrr-type Roux-en-Y esophagojejunostomy can be recommended as an adaptable method of digestive reconstruction after total gastrectomy for gastric cancer because of its avoiding reflux esophagitis, maintaining better nutritional status and quality of life, and simpler procedure.
Adult ; Aged ; Anastomosis, Roux-en-Y ; methods ; Esophagus ; surgery ; Female ; Gastrectomy ; Humans ; Jejunum ; surgery ; Male ; Middle Aged ; Postoperative Period ; Reconstructive Surgical Procedures ; methods ; Stomach Neoplasms ; surgery
5.Clinical evaluation of efficacy and safety of nateglinide in the treatment of type 2 diabetes.
Yu-Xiu LI ; Guo-Xian DING ; Qi-Fu LI ; Li CHEN ; Guo-Liang HU ; Qiu-He JI ; Shou-Jun WANG ; Yan GUO ; Rong LUO ; Wei-Kai HOU ; Pu-Neng WANG ; Nan-Yan ZHANG ; Ya-Ping ZHANG ; Heng WANG
Acta Academiae Medicinae Sinicae 2008;30(2):211-213
OBJECTIVETo evaluate the efficacy and safety of nateglinide, a new antidiabetic agent, in the treatment of type 2 diabetes.
METHODSA total of 219 treatment-naïve patients with type 2 diabetes from 6 centers were enrolled in this study and blindly divided into nateglinide group (n = 105) and repaglinide group (n = 114). In all patients, the disease was confirmed for at least three months. The whole observation lasted for 12 weeks. The efficacy indicators measured include glycohemoglobin A1c (HbA1c), fasting blood glucose, and 2 hours postprandial blood glucose, and the safety parameters measured included renal and hepatic function, serum lipids, and blood and urea profiles.
RESULTSSimilar decreases in fasting blood glucose, 2 hours postprandial blood glucose, and HbA1 c were found in both nateglinide group and repaglinide group without significant differences. No severe adverse events were noted. The hypoglycemia event reports were not significantly different between these two groups.
CONCLUSIONNateglinide is an effective and safe drug in treating type 2 diabetes.
Blood Glucose ; drug effects ; Cyclohexanes ; administration & dosage ; adverse effects ; therapeutic use ; Diabetes Mellitus, Type 2 ; drug therapy ; Drug Administration Schedule ; Female ; Humans ; Hypoglycemic Agents ; administration & dosage ; adverse effects ; therapeutic use ; Male ; Middle Aged ; Phenylalanine ; administration & dosage ; adverse effects ; analogs & derivatives ; therapeutic use ; Treatment Outcome
6.Analysis on the factors related to rabies epidemic in China, in 2005.
Miao SONG ; Qing TANG ; Zhen XU ; Hao LI ; Ding-Ming WANG ; Zhao-Jun MO ; Li-Dong GAO ; Shou-Heng GUO ; Feng-Cai ZHU ; Dai-Lin HU ; Xian-Jun WANG
Chinese Journal of Epidemiology 2006;27(11):956-959
OBJECTIVETo analyse the related epidemic factors of rabies and to provide basic evidence for developing rabies control and prevention programs in China.
METHODSPossible factors that causing rabies epidemics in the southern part of China were obtained through collecting both epidemic and surveillance data of rabies in 2005, and to analyse every factor by software of Excel 2002.
RESULTSThe number of rabies cases was 2548 in 2005. Among 885 cases being investigated, 60.56%, 49.04%, 96.16% had not had any chance to receive treatment, vaccine or immunoglobulin. Among the exposed persons, 89.95% received treatment on wounds and 94.93% were immunized, and 8.56% received immunoglobulin. 94.86% of them accomplished the full rabies post-exposure prophylaxis course, but 8.56% of them did not accomplish it. 88.50% of the cases and 92% of the persons under exposure were bitten by dogs. The density of dogs was 3.20-13.37 per 100 persons. The vaccination coverage rates among dogs were 5.31% -75.11% with a positive rate of 2.93 % -6.40%.
CONCLUSIONFactors as: low rate of post-exposure prophylaxis and failed to have finished the necessary post-exposure treatment (PET) of the cases, nonstandard PET in hospital or local clinic, low rabies vaccination coverage and high infectivity of rabies virus in animal host (mainly for dog) might be responsible for rabies epidemics in China, in 2005.
Animals ; Bites and Stings ; China ; epidemiology ; Disease Outbreaks ; Dogs ; Humans ; Population Surveillance ; Post-Exposure Prophylaxis ; Rabies ; epidemiology ; Rabies Vaccines ; administration & dosage
7.The relationship between inflammatory factors and the risk of breast cancer in Kailuan cohort
Gang WANG ; Ni LI ; Xiao-shuang FENG ; Zhang-yan LV ; Luo-pei WEI ; Xin LI ; Yu-heng CHEN ; Lan-wei GUO ; Hong-da CHEN ; Jian YIN ; Hong CUI ; Jian-song REN ; Shou-ling WU ; Ju-fang SHI ; Min DAI ; Jie HE
Chinese Journal of Disease Control & Prevention 2019;23(5):517-521
Objective To investigate whether elevated baseline levels of high sensitivity C-Reactive Protein (hsCRP) and neutrophil (NE) are associated with an increased risk of breast cancer in Kailuan female cohort. Methods Females from Kailuan cohort (2006-2007) were included in this study. Information on check-up, hsCRP and NE were collected at baseline for all subjects. Multivariable Cox proportional hazards regression models were used to calculate hazard ratios (HR) and 95% confidence intervals (95%CI) of association between baseline hsCRP and NE values and breast cancer risk. Results By December 31, 2015, a total of 18 866 participants were enrolled in this study. During the follow-up, 183 new cases of breast cancer were observed. All participants were divided into three groups according to the level of hsCRP (<1 mg/L, 1-3 mg/L and >3 mg/L). The cumulative incidence of breast cancer were 829/105, 1 211/105 and 1 495/105 in these 3 groups, respectively ( 2=12.08, P=0.002). Compared with participants with lower hsCRP levels (<1 mg/L), individuals with the highest hsCRP (>3 mg/L) levels had significantly increased risk of breast cancer (HR=1.71,95%CI: 1.18-2.47, P=0.005), howerver, we didn’t find the statistically significant association between NE level (<3.70×109/Lvs. ≥3.70×109/L) and the risk of brease cancer (P>0.05). Conclusions Elevated levels of hsCRP at baseline might increase the risk of breast cancer in females.
8.An outbreak of human Streptococcus suis serotype 2 infections presenting with toxic shock syndrome in Sichuan, China.
Wei-zhong YANG ; Hong-jie YU ; Huai-qi JING ; Jian-guo XU ; Zhi-hai CHEN ; Xiao-ping ZHU ; Hua WANG ; Xue-cCheng LIU ; Shi-wen WANG ; Lun-guang LIU ; Rong-qiang ZU ; Long-ze LUO ; Ni-juan XIANG ; Hong-lu LIU ; Wen-jun ZHONG ; Li LIU ; Ling MENG ; Heng YUAN ; Yong-jun GAO ; Hua-mao DU ; Yang-bin OU ; Chang-yun YE ; Dong JIN ; Qiang LV ; Zhi-gang CUI ; Yan HUANG ; Shou-yin ZHANG ; Xiang-dong AN ; Ting HUANG ; Xing-yu ZHOU ; Liao FENG ; Qi-di PANG ; Yue-long SHU ; Yu WANG
Chinese Journal of Epidemiology 2006;27(3):185-191
OBJECTIVEIn mid-July 2005, five patients presented with septic shock to a hospital in Ziyang city in Sichuan, China, to identify the etiology of the unknown reason disease, an epidemiological, clinical, and laboratory study were conducted.
METHODSAn enhanced surveillance program were established in Sichuan, the following activities were introduced: active case finding in Sichuan of (a) laboratory diagnosed Streptococcus suis infection and (b) clinically diagnosed probable cases with exposure history; supplemented by (c) monitoring reports on meningococcal meningitis. Streptococcus suis serotype 2 infection was confirmed by culture and biochemical reactions, followed by sequencing for specific genes for serotype and virulence factors.
RESULTSFrom June 10 to August 21, 2005, 68 laboratory confirmed cases of human Streptococcus suis infections were reported. All were villagers who gave a history of direct exposure to deceased or sick pigs in their backyards where slaughtering was performed. Twenty six (38%) presented with toxic shock syndrome of which 15 (58%) died. Other presentations were septicaemia or meningitis. All isolates were tested positive for genes for tuf, species-specific 16S rRNA, cps2J, mrp, ef and sly. There were 136 clinically diagnosed probable cases with similar exposure history but incomplete laboratory investigations.
CONCLUSIONAn outbreak of human Streptococcus suis serotype 2 infections occurred in villagers after direct exposure to deceased or sick pigs in Sichuan. Prohibition of slaughtering in backyards brought the outbreak to a halt. A virulent strain of the bacteria is speculated to be in circulation, and is responsible for the unusual presentation of toxic shock syndrome with high case fatality.
Animals ; Bacteremia ; epidemiology ; microbiology ; China ; epidemiology ; Disease Outbreaks ; Humans ; Meningitis, Bacterial ; epidemiology ; microbiology ; Shock, Septic ; epidemiology ; microbiology ; Streptococcal Infections ; epidemiology ; microbiology ; veterinary ; Streptococcus suis ; isolation & purification ; Swine ; Swine Diseases ; microbiology
9.Role of Diabetes Mellitus on Treatment Effects in Drug-susceptible Initial Pulmonary Tuberculosis Patients in China.
Yan MA ; ; Mai Ling HUANG ; ; Tao LI ; Jian DU ; ; Wei SHU ; ; Shi Heng XIE ; ; Hong Hong WANG ; ; Guo Feng ZHU ; Shou Yong TAN ; Yan Yong FU ; Li Ping MA ; Lian Ying ZHANG ; Fei Ying LIU ; Dai Yu HU ; Yan Ling ZHANG ; Xiang Qun LI ; Yu Hong LIU ; ; Liang LI ;
Biomedical and Environmental Sciences 2017;30(9):671-675
We assessed the role of diabetes mellitus (DM) on treatment effects in drug-susceptible initial pulmonary tuberculosis (PTB) patients. A prospective study was conducted in eight provinces of China from October 2008 to December 2010. We enrolled 1,313 confirmed drug-susceptible initial PTB patients, and all subjects received the treatment regimen (2H3R3E3Z3/4H3R3) as recommended by the national guidelines. Of the 1,313 PTB patients, 157 (11.9%) had DM; these patients had more sputum smear-positive rates at the end of the second month [adjusted odds ratios (aOR) 2.829, 95% confidence intervals (CI) 1.783-4.490], and higher treatment failure (aOR 2.120, 95% CI 1.565-3.477) and death rates (aOR 1.536, 95% CI 1.011-2.628). DM was a contributing factor for culture-positive rates at the end of the second month and treatment failure and death of PTB patients, thus playing an unfavorable role in treatment effects of PTB.
Antitubercular Agents
;
therapeutic use
;
China
;
epidemiology
;
Diabetes Mellitus
;
epidemiology
;
therapy
;
Female
;
Humans
;
Male
;
Mycobacterium tuberculosis
;
drug effects
;
Tuberculosis, Pulmonary
;
complications
;
drug therapy
;
epidemiology
;
microbiology
10.Risk of Treatment Failure in Patients with Drug-susceptible Pulmonary Tuberculosis in China.
Ni WANG ; Yan MA ; ; Yu Hong LIU ; ; Jian DU ; ; Hui ZHANG ; Shi Heng XIE ; ; Kun ZHU ; ; Xiao Ya LYU ; ; Wei SHU ; ; Hong Hong WANG ; ; Guo Feng ZHU ; Shou Yong TAN ; Yan Yong FU ; Li Ping MA ; Lian Ying ZHANG ; Fei Ying LIU ; Dai Yu HU ; Yan Ling ZHANG ; Xiang Qun LI ; Liang LI ;
Biomedical and Environmental Sciences 2016;29(8):612-617
The objective of this prospective study of the risks of treatment failure in patients with drug-susceptible pulmonary tuberculosis (PTB) was to provide reference data to help develop a disease control strategy. Participants were recruited in eight provinces of China from October 2008 to December 2010. A total of 1447 patients with drug-susceptible PTB and older than 15 years of age were enrolled. Demographic characteristics, bacteriological test results, and patient outcome, i.e., cure or treatment failure were recorded and compared using the chi-square or Fisher's exact tests. Multivariate logistic regression was used to identify factors associated with risk of treatment failure. Of the 1447 patients who were enrolled, 1349 patients (93.2%) were successfully treated and 98 (6.8%) failed treatment. Failure was significantly associated with age 365 years [odds ratio (OR)=2.522, 95% confidence interval (CI): (1.097-5.801)], retreatment [OR=2.365, 95% CI: (1.276-4.381)], missed medicine [OR=1.836, 95% CI: (1.020-3.306)], treatment not observed [OR=1.879 95% CI: (1.105-3.195)], and positive culture result after the first [OR=1.971, 95% CI: (1.080-3.597)] and second month [OR=4.659, 95% CI: (2.590-8.382)]. The risk factors associated with treatment failure were age 365 years, retreatment, missed medication, treatment not observed, and positive culture at the end of month 1 or month 2. These risk factors should be monitored during treatment and interventions carried out to reduce or prevent treatment failure and optimize treatment success.
Adolescent
;
Adult
;
Aged
;
Antitubercular Agents
;
therapeutic use
;
China
;
epidemiology
;
Female
;
Humans
;
Male
;
Middle Aged
;
Mycobacterium tuberculosis
;
drug effects
;
physiology
;
Prospective Studies
;
Retreatment
;
Risk Factors
;
Treatment Failure
;
Tuberculosis, Multidrug-Resistant
;
drug therapy
;
epidemiology
;
microbiology
;
Tuberculosis, Pulmonary
;
drug therapy
;
epidemiology
;
microbiology
;
Young Adult